ACORQ
Price:
$0.01
Market Cap:
$821.03K
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in adults with multiple sclerosis; and Inbrija, an inhaled levodopa for intermittent treatment of OFF periods in people with Parkinson's disease treated with a carbidopa/levodopa regimen. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, it has collaboration and license agreement with Biogen Inc. for the development and commercialization of Ampyra. The company was incorporated in 1995 and is headquartered in Pearl River, New York. On April 1, 20...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2006-02-10
Stock Exchange
OTC
Ticker
ACORQ
According to Acorda Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.00. This represents a change of -99.89% compared to the average of -0.05 of the last 4 quarters.
The mean historical PE Ratio of Acorda Therapeutics, Inc. over the last ten years is 4.29. The current -0.00 PE Ratio has changed -100.12% with respect to the historical average. Over the past ten years (40 quarters), ACORQ's PE Ratio was at its highest in in the December 2014 quarter at 213.67. The PE Ratio was at its lowest in in the March 2016 quarter at -94.98.
Average
4.29
Median
-0.04
Minimum
-4.10
Maximum
28.13
Discovering the peaks and valleys of Acorda Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 73.42%
Maximum Annual PE Ratio = 28.13
Minimum Annual Increase = -592.69%
Minimum Annual PE Ratio = -4.10
| Year | PE Ratio | Change |
|---|---|---|
| 2023 | -0.01 | -67.91% |
| 2022 | -0.04 | -5.64% |
| 2021 | -0.04 | -27.30% |
| 2020 | -0.06 | -5.36% |
| 2019 | -0.06 | -101.63% |
| 2018 | 3.62 | -592.69% |
| 2017 | -0.74 | -82.04% |
| 2016 | -4.10 | -114.56% |
| 2015 | 28.13 | 73.42% |
| 2014 | 16.22 | 31.45% |
The current PE Ratio of Acorda Therapeutics, Inc. (ACORQ) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-0.03
5-year avg
-0.04
10-year avg
4.29
Acorda Therapeutics, Inc.’s PE Ratio is greater than Goodbody Health Limited (-0.00), less than New You, Inc. (-0.00), less than Advanzeon Solutions, Inc. (0), greater than Genesis Healthcare, Inc. (-0.00), greater than MagForce AG (-329.76), less than Hempfusion Wellness Inc. (0), greater than NutraLife BioSciences, Inc. (-0.00), greater than Navidea Biopharmaceuticals, Inc. (-0.00), greater than Nanomix Corporation (-0.00), greater than Generex Biotechnology Corporation (-0.00),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.00 | $365.00 | |
| -0.00 | $14.99K | |
| 0 | $11.99K | |
| -0.00 | $12.15K | |
| -329.76 | $11.97K | |
| 0 | $1.64K | |
| -0.00 | $17.66K | |
| -0.00 | $10.01K | |
| -0.00 | $9.80K | |
| -0.00 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acorda Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Acorda Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Acorda Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Acorda Therapeutics, Inc. (ACORQ)?
What is the highest PE Ratio for Acorda Therapeutics, Inc. (ACORQ)?
What is the 3-year average PE Ratio for Acorda Therapeutics, Inc. (ACORQ)?
What is the 5-year average PE Ratio for Acorda Therapeutics, Inc. (ACORQ)?
How does the current PE Ratio for Acorda Therapeutics, Inc. (ACORQ) compare to its historical average?